Biotech Value Stocks Climb Out of Their Sick Bed

📆 11/3/2019 3:30 AM
📰 WSJ

⏱ Reading Time:
17 sec. here
2 min. at publisher
📊 Quality Score:
News: 10%
Publisher: 63%

Business News News

Business Business Latest News,Business Business Headlines

Heard on the Street: Recent good news from Biogen and Bristol-Myers Squibb bolsters hope that years of weak performance may be ending

The biotechnology universe is divided into two groups.

The majority are companies without profits, or even sales, chasing a scientific breakthrough and the resulting massive payoff for investors. A much smaller group of companies have graduated to megacap status. Like most companies of their size, these sport massive profits and cash flows, with much less growth potential.

Write Comment

No, you are correct🧡

I guess that could happen))😀

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Berkshire Hathaway’s Quarterly Earnings Fell as Unrealized Investment Gains DeclinedWarren Buffett’s Berkshire Hathaway said third-quarter earnings fell as unrealized investment gains declined but operating earnings climbed In other words...he made money. Bail! There are plenty of other choices. It's a pity, but no better idea.
Source: WSJ - 🏆 98. / 63 Read more »